Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Double-masked Prospective Multicenter Trial to Evaluate the Efficacy and Safety of the Oral Anticoagulant Dimolegin® Compared With Low Molecular Weight Heparin (Clexane®) as a Means of Preventing VTE in Patients Undergoing Elective Endoprosthetics of Large Joints

NCT07124819 is registered in ClinicalTrials.gov with Avexima Diol LLC as lead sponsor.

NCT NCT07124819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07124819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Double-masked Prospective Multicenter Trial to Evaluate the Efficacy and Safety of the Oral Anticoagulant Dimolegin® Compared With Low Molecular Weight Heparin (Clexane®) as a Means of Preventing VTE in Patients Undergoing Elective Endoprosthetics of Large Joints
Lead sponsor
Avexima Diol LLC
Phase
Phase 3
Overall status
Completed
Start date
July 22, 2024
Completion date
January 14, 2025
Enrollment
215 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, replacement, hip, arthroplasty, replacement, knee, prevention, venous thromboembolism (vte)